よむ、つかう、まなぶ。
【参考資料３】【英版R4.1.17】Nippon AMR One Health Report (NAOR) 2020 (2 ページ)
出典
| 公開元URL | https://www.mhlw.go.jp/stf/newpage_23261.html |
| 出典情報 | 国際的に脅威となる感染症対策関係閣僚会議 薬剤耐性ワンヘルス動向調査検討会（第9回 1／17）《厚生労働省》 |
ページ画像
ダウンロードした画像を利用する際は「出典情報」を明記してください。
低解像度画像をダウンロード
プレーンテキスト
資料テキストはコンピュータによる自動処理で生成されており、完全に資料と一致しない場合があります。
テキストをコピーしてご利用いただく際は資料と付け合わせてご確認ください。
TABLE OF CONTENTS
Preface ........................................................................................................................................ 4
Abbreviations .............................................................................................................................. 5
Types and Abbreviations of Antimicrobials ................................................................................. 5
Executive Summary .................................................................................................................... 8
Outcome Indices for the Action Plan ......................................................................................... 11
Current Status of Antimicrobial-resistant Bacteria in Japan ..................................................... 12
(1) Humans............................................................................................................................................................ 12
1) Gram-negative bacteria .................................................................................................................................. 12
2) Gram-positive bacteria .................................................................................................................................. 15
3) Antimicrobial-resistant bacteria infection ...................................................................................................... 20
4) Other antimicrobial-resistant bacteria ............................................................................................................ 21
5) Mycobacterium tuberculosis .......................................................................................................................... 29
6) Clostridioides (Clostridium) difficile infection .............................................................................................. 30
7) Status of health care associated infection ...................................................................................................... 30
8) Survey of infection treatment and control and the disease burden at hospitals .............................................. 31
9) Survey of infections and antimicrobial use at facilities for the elderly .......................................................... 33
(2) Animals ........................................................................................................................................................... 35
1) Bacteria derived from food-producing animals ............................................................................................. 35
2) Aquatic animal farming ................................................................................................................................. 47
3) Companion animals ....................................................................................................................................... 49
4) Wild animals.................................................................................................................................................. 55
(3) Food................................................................................................................................................................. 56
(4) Environment .................................................................................................................................................... 56
Current Volume of Use of Antimicrobials in Japan ................................................................... 60
(1) Antimicrobials for humans (based on volume of sales) .................................................................................. 60
(2) Veterinary drugs .............................................................................................................................................. 64
1) Food-producing animals ................................................................................................................................ 66
2) Aquatic animals ............................................................................................................................................. 66
3) Companion animals ....................................................................................................................................... 68
(3) Antimicrobial feed additives ........................................................................................................................... 68
(4) Agrochemicals ................................................................................................................................................. 69
(5) Current status of antimicrobial use in Japan .................................................................................................... 69
(6) Research into antimicrobial stewardship ......................................................................................................... 72
(7) Environment .................................................................................................................................................... 82
Public Awareness regarding Antimicrobial Resistance in Japan ................................................ 83
(1) Surveys of the general public .......................................................................................................................... 83
1
Preface ........................................................................................................................................ 4
Abbreviations .............................................................................................................................. 5
Types and Abbreviations of Antimicrobials ................................................................................. 5
Executive Summary .................................................................................................................... 8
Outcome Indices for the Action Plan ......................................................................................... 11
Current Status of Antimicrobial-resistant Bacteria in Japan ..................................................... 12
(1) Humans............................................................................................................................................................ 12
1) Gram-negative bacteria .................................................................................................................................. 12
2) Gram-positive bacteria .................................................................................................................................. 15
3) Antimicrobial-resistant bacteria infection ...................................................................................................... 20
4) Other antimicrobial-resistant bacteria ............................................................................................................ 21
5) Mycobacterium tuberculosis .......................................................................................................................... 29
6) Clostridioides (Clostridium) difficile infection .............................................................................................. 30
7) Status of health care associated infection ...................................................................................................... 30
8) Survey of infection treatment and control and the disease burden at hospitals .............................................. 31
9) Survey of infections and antimicrobial use at facilities for the elderly .......................................................... 33
(2) Animals ........................................................................................................................................................... 35
1) Bacteria derived from food-producing animals ............................................................................................. 35
2) Aquatic animal farming ................................................................................................................................. 47
3) Companion animals ....................................................................................................................................... 49
4) Wild animals.................................................................................................................................................. 55
(3) Food................................................................................................................................................................. 56
(4) Environment .................................................................................................................................................... 56
Current Volume of Use of Antimicrobials in Japan ................................................................... 60
(1) Antimicrobials for humans (based on volume of sales) .................................................................................. 60
(2) Veterinary drugs .............................................................................................................................................. 64
1) Food-producing animals ................................................................................................................................ 66
2) Aquatic animals ............................................................................................................................................. 66
3) Companion animals ....................................................................................................................................... 68
(3) Antimicrobial feed additives ........................................................................................................................... 68
(4) Agrochemicals ................................................................................................................................................. 69
(5) Current status of antimicrobial use in Japan .................................................................................................... 69
(6) Research into antimicrobial stewardship ......................................................................................................... 72
(7) Environment .................................................................................................................................................... 82
Public Awareness regarding Antimicrobial Resistance in Japan ................................................ 83
(1) Surveys of the general public .......................................................................................................................... 83
1